{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:52:41Z","timestamp":1792806761666,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,6]],"date-time":"2010-04-06T00:00:00Z","timestamp":1270512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11481-010-9201-3","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T05:45:49Z","timestamp":1270446349000},"page":"271-277","source":"Crossref","is-referenced-by-count":226,"title":["Epstein\u2013Barr Virus Infection and Multiple Sclerosis: A Review"],"prefix":"10.1007","volume":"5","author":[{"given":"Alberto","family":"Ascherio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassandra L.","family":"Munger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,6]]},"reference":[{"issue":"9","key":"9201_CR1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-009-9367-2","volume":"24","author":"C Ahlgren","year":"2009","unstructured":"Ahlgren C et al (2009) A population-based case\u2013control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol 24(9):541\u2013552","journal-title":"Eur J Epidemiol"},{"issue":"15","key":"9201_CR2","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","volume":"291","author":"S Alotaibi","year":"2004","unstructured":"Alotaibi S et al (2004) Epstein\u2013Barr virus in pediatric multiple sclerosis. JAMA 291(15):1875\u20131879","journal-title":"JAMA"},{"issue":"4","key":"9201_CR3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007a) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61(4):288\u2013299","journal-title":"Ann Neurol"},{"issue":"6","key":"9201_CR4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007b) Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61(6):504\u2013513","journal-title":"Ann Neurol"},{"key":"9201_CR5","doi-asserted-by":"crossref","unstructured":"Ascherio A, Munger KL (2010) Epidemiology of multiple sclerosis: environmental factors, In: Luchinetti and Hohlfeld, eds. Multiple Sclerosis 3, 1st ed. Philadelphia: Saunders, Elsevier 57\u201382. Copyright \u00a9 2010 Elsevier. All rights reserved","DOI":"10.1016\/B978-1-4160-6068-0.00004-8"},{"issue":"24","key":"9201_CR6","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio A et al (2001) Epstein\u2013barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286(24):3083\u20133088","journal-title":"JAMA"},{"issue":"12","key":"9201_CR7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"JF Bach","year":"2002","unstructured":"Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347(12):911\u2013920","journal-title":"N Engl J Med"},{"issue":"9","key":"9201_CR8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","volume":"6","author":"B Banwell","year":"2007","unstructured":"Banwell B et al (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6(9):773\u2013781","journal-title":"Lancet Neurol"},{"issue":"1","key":"9201_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.58.1.31","volume":"58","author":"E Bech","year":"2002","unstructured":"Bech E et al (2002) A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 58(1):31\u201336","journal-title":"Neurology"},{"issue":"10","key":"9201_CR10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/jnnp.2004.048504","volume":"76","author":"D Buljevac","year":"2005","unstructured":"Buljevac D et al (2005) Epstein\u2013Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76(10):1377\u20131381","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9201_CR11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","volume":"115","author":"S Cepok","year":"2005","unstructured":"Cepok S et al (2005) Identification of Epstein\u2013Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115(5):1352\u20131360","journal-title":"J Clin Invest"},{"issue":"10","key":"9201_CR12","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","volume":"15","author":"ET Chang","year":"2006","unstructured":"Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1765\u20131777","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"9201_CR13","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1172\/JCI25078","volume":"115","author":"SC Clute","year":"2005","unstructured":"Clute SC et al (2005) Cross-reactive influenza virus-specific CD8 T cells contribute to lymphoproliferation in Epstein\u2013Barr virus-associated infectious mononucleosis. J Clin Invest 115(12):3602\u20133612","journal-title":"J Clin Invest"},{"issue":"13 Pt 2","key":"9201_CR14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","volume":"70","author":"PL Jager De","year":"2008","unstructured":"De Jager PL et al (2008) Integrating risk factors: HLA-DRB1*1501 and Epstein\u2013Barr virus in multiple sclerosis. Neurology 70(13 Pt 2):1113\u20131118","journal-title":"Neurology"},{"issue":"6","key":"9201_CR15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","volume":"63","author":"GN DeLorenze","year":"2006","unstructured":"DeLorenze GN et al (2006) Epstein\u2013Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63(6):839\u2013844","journal-title":"Arch Neurol"},{"issue":"6545","key":"9201_CR16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/377150a0","volume":"377","author":"GC Ebers","year":"1995","unstructured":"Ebers GC et al (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377(6545):150\u2013151","journal-title":"Nature"},{"issue":"1","key":"9201_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","volume":"73","author":"RA Farrell","year":"2009","unstructured":"Farrell RA et al (2009) Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73(1):32\u201338","journal-title":"Neurology"},{"issue":"7","key":"9201_CR18","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ijc.22813","volume":"121","author":"BJ Feng","year":"2007","unstructured":"Feng BJ et al (2007) Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer 121(7):1550\u20131555","journal-title":"Int J Cancer"},{"issue":"3","key":"9201_CR19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1191\/1352458505ms1185oa","volume":"11","author":"JE Friedman","year":"2005","unstructured":"Friedman JE et al (2005) A randomized clinical trial of valacyclovir in multiple sclerosis. Mult Scler 11(3):286\u2013295","journal-title":"Mult Scler"},{"key":"9201_CR20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0301-0082(95)80008-V","volume":"47","author":"CR Gale","year":"1995","unstructured":"Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47:425\u2013448","journal-title":"Prog Neurobiol"},{"key":"9201_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-230X(08)60714-9","volume":"67","author":"JW Gratama","year":"1995","unstructured":"Gratama JW, Ernberg I (1995) Molecular epidemiology of Epstein\u2013Barr virus infection. Adv Cancer Res 67:197\u2013255","journal-title":"Adv Cancer Res"},{"issue":"1\u20132","key":"9201_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2006.08.008","volume":"180","author":"F Gronen","year":"2006","unstructured":"Gronen F et al (2006) Frequency analysis of HLA-B7-restricted Epstein\u2013Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol 180(1\u20132):185\u2013192","journal-title":"J Neuroimmunol"},{"issue":"7","key":"9201_CR23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser SL et al (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358(7):676\u2013688","journal-title":"N Engl J Med"},{"issue":"14","key":"9201_CR24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","volume":"349","author":"H Hjalgrim","year":"2003","unstructured":"Hjalgrim H et al (2003) Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349(14):1324\u20131332","journal-title":"N Engl J Med"},{"key":"9201_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","volume":"132","author":"P Hollsberg","year":"2003","unstructured":"Hollsberg P et al (2003) Altered CD8+T cell responses to selected Epstein\u2013Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 132:137\u2013143","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"9201_CR26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13550280490499524","volume":"10","author":"T Holmoy","year":"2004","unstructured":"Holmoy T et al (2004) Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein\u2013Barr virus and myelin basic protein. J Neurovirology 10(5):278\u2013283","journal-title":"J Neurovirology"},{"issue":"10","key":"9201_CR27","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.20081761","volume":"206","author":"D Iwakiri","year":"2009","unstructured":"Iwakiri D et al (2009) Epstein\u2013Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. J Exp Med 206(10):2091\u20132099","journal-title":"J Exp Med"},{"issue":"Pt 7","key":"9201_CR28","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/brain\/awn108","volume":"131","author":"S Jilek","year":"2008","unstructured":"Jilek S et al (2008) Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 131(Pt 7):1712\u20131721","journal-title":"Brain"},{"key":"9201_CR29","first-page":"2603","volume-title":"Fields virology","author":"ED Kieff","year":"2007","unstructured":"Kieff ED, Rickinson AB (2007) Epstein\u2013Barr virus and its replication. In: Knipe DM et al (eds) Fields virology, vol 2, 5th edn. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, pp 2603\u20132654","edition":"5"},{"issue":"4","key":"9201_CR30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1084\/jem.20041337","volume":"201","author":"SK Kim","year":"2005","unstructured":"Kim SK et al (2005) Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med 201(4):523\u2013533","journal-title":"J Exp Med"},{"issue":"1","key":"9201_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0895-4356(00)00268-7","volume":"54","author":"JF Kurtzke","year":"2001","unstructured":"Kurtzke JF, Heltberg A (2001) Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 54(1):1\u201322","journal-title":"J Clin Epidemiol"},{"key":"9201_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F (2006) Spectrum of Epstein\u2013Barr virus-associated diseases. Annu Rev Pathol 1:375\u2013404","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"9201_CR33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","volume":"3","author":"HL Lang","year":"2002","unstructured":"Lang HL et al (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3(10):940\u2013943","journal-title":"Nat Immunol"},{"issue":"20","key":"9201_CR34","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","volume":"293","author":"LI Levin","year":"2005","unstructured":"Levin LI et al (2005) Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293(20):2496\u20132500","journal-title":"JAMA"},{"key":"9201_CR35","doi-asserted-by":"crossref","unstructured":"Levin LI et al (2010) Primary infection with the Epstein\u2013Barr virus and risk of multiple sclerosis. Ann Neurol. doi: 10.1002\/ana.21978","DOI":"10.1002\/ana.21978"},{"issue":"2","key":"9201_CR36","first-page":"141","volume":"117","author":"JW Lindsey","year":"2008","unstructured":"Lindsey JW et al (2008) Epstein\u2013Barr virus genotypes in multiple sclerosis. Acta Neurol Scand 117(2):141\u2013144","journal-title":"Acta Neurol Scand"},{"issue":"Pt 6","key":"9201_CR37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awl067","volume":"129","author":"JD Lunemann","year":"2006","unstructured":"Lunemann JD et al (2006) Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129(Pt 6):1493\u20131506","journal-title":"Brain"},{"issue":"8","key":"9201_CR38","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","volume":"205","author":"JD Lunemann","year":"2008","unstructured":"Lunemann JD et al (2008) EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-{gamma} and IL-2. J Exp Med 205(8):1763\u20131773","journal-title":"J Exp Med"},{"key":"9201_CR39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00868517","volume":"243","author":"J Lycke","year":"1996","unstructured":"Lycke J et al (1996) Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol 243:214\u2013224","journal-title":"J Neurol"},{"issue":"4","key":"9201_CR40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000108113","volume":"28","author":"J Massa","year":"2007","unstructured":"Massa J et al (2007) Plasma titers of antibodies against Epstein\u2013Barr virus BZLF1 and risk of multiple sclerosis. Neuroepidemiology 28(4):214\u2013215","journal-title":"Neuroepidemiology"},{"key":"9201_CR41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.2910340506","volume":"34","author":"M Melbye","year":"1984","unstructured":"Melbye M et al (1984) Early primary infection and high Epstein\u2013Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma. Int J Cancer 34:619\u2013623","journal-title":"Int J Cancer"},{"issue":"6","key":"9201_CR42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/511984","volume":"195","author":"AM Moormann","year":"2007","unstructured":"Moormann AM et al (2007) Exposure to holoendemic malaria results in suppression of Epstein\u2013Barr virus-specific T cell immunosurveillance in kenyan children. J Infect Dis 195(6):799\u2013808","journal-title":"J Infect Dis"},{"issue":"24","key":"9201_CR43","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","volume":"25","author":"M Moutschen","year":"2007","unstructured":"Moutschen M et al (2007) Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein\u2013Barr virus vaccine in healthy adults. Vaccine 25(24):4697\u20134705","journal-title":"Vaccine"},{"key":"9201_CR44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.1998.tb07320.x","volume":"98","author":"M Munch","year":"1998","unstructured":"Munch M et al (1998) A single subtype of Epstein\u2013Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 98:395\u2013399","journal-title":"Acta Neurol Scand"},{"key":"9201_CR45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","volume":"62","author":"KL Munger","year":"2004","unstructured":"Munger KL et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60\u201365","journal-title":"Neurology"},{"issue":"23","key":"9201_CR46","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL et al (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832\u20132838","journal-title":"JAMA"},{"issue":"1","key":"9201_CR47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","volume":"64","author":"TR Nielsen","year":"2007","unstructured":"Nielsen TR et al (2007) Multiple sclerosis after infectious mononucleosis. Arch Neurol 64(1):72\u201375","journal-title":"Arch Neurol"},{"key":"9201_CR48","doi-asserted-by":"crossref","unstructured":"Peferoen LA et al (2009) Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain. doi: 10.1093\/brain\/awp296","DOI":"10.1093\/brain\/awp296"},{"issue":"11","key":"9201_CR49","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","volume":"24","author":"MP Pender","year":"2003","unstructured":"Pender MP (2003) Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24(11):584\u2013588","journal-title":"Trends Immunol"},{"issue":"5","key":"9201_CR50","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/jnnp.2008.161018","volume":"80","author":"MP Pender","year":"2009","unstructured":"Pender MP et al (2009) Decreased T-cell reactivity to Epstein\u2013Barr virus-infected lymphoblastoid cell lines in multiple sclerosis. J Neurol Neurosurg Psychiatry 80(5):498\u2013505","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"9201_CR51","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","volume":"67","author":"D Pohl","year":"2006","unstructured":"Pohl D et al (2006) High seroprevalence of Epstein\u2013Barr virus in children with multiple sclerosis. Neurology 67(11):2063\u20132065","journal-title":"Neurology"},{"issue":"4","key":"9201_CR52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000201564","volume":"32","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan SV et al (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology 32(4):257\u2013262","journal-title":"Neuroepidemiology"},{"issue":"1","key":"9201_CR53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-510X(99)00298-1","volume":"173","author":"KH Rand","year":"2000","unstructured":"Rand KH et al (2000) Epstein\u2013Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 173(1):32\u201339","journal-title":"J Neurol Sci"},{"key":"9201_CR54","first-page":"2655","volume-title":"Fields virology, vol. 2","author":"AB Rickinson","year":"2007","unstructured":"Rickinson AB, Kieff E (2007) Epstein\u2013Barr virus. In: Knipe DM et al (eds) Fields virology, vol 2, 5th edn. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, pp 2655\u20132700","edition":"5"},{"issue":"6","key":"9201_CR55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semcancer.2009.07.004","volume":"19","author":"M Rowe","year":"2009","unstructured":"Rowe M et al (2009) Burkitt's lymphoma: the rosetta stone deciphering Epstein\u2013Barr virus biology. Semin Cancer Biol 19(6):377\u2013388","journal-title":"Semin Cancer Biol"},{"key":"9201_CR56","doi-asserted-by":"crossref","unstructured":"Sargsyan SA et al (2010) Absence of Epstein\u2013Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. doi: 10.1212\/WNL.0b013e3181d865a1","DOI":"10.1212\/WNL.0b013e3181d865a1"},{"issue":"12","key":"9201_CR57","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B et al (2007) Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain. J Exp Med 204(12):2899\u20132912","journal-title":"J Exp Med"},{"issue":"7","key":"9201_CR58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1352458506072983","volume":"13","author":"KC Simon","year":"2007","unstructured":"Simon KC et al (2007) Variation in the Epstein\u2013Barr virus receptor, CR2, and risk of multiple sclerosis. Mult Scler 13(7):947\u2013948","journal-title":"Mult Scler"},{"issue":"12","key":"9201_CR59","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal EM et al (2007) Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults. J Infect Dis 196(12):1749\u20131753","journal-title":"J Infect Dis"},{"issue":"12","key":"9201_CR60","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","volume":"62","author":"P Sundstrom","year":"2004","unstructured":"Sundstrom P et al (2004) An altered immune response to Epstein\u2013Barr virus in multiple sclerosis: a prospective study. Neurology 62(12):2277\u20132282","journal-title":"Neurology"},{"issue":"4","key":"9201_CR61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1074-7613(01)00210-2","volume":"15","author":"N Sutkowski","year":"2001","unstructured":"Sutkowski N et al (2001) Epstein\u2013Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15(4):579\u2013589","journal-title":"Immunity"},{"issue":"9","key":"9201_CR62","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1352458508094641","volume":"14","author":"A Tai","year":"2008","unstructured":"Tai A et al (2008) Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler 14(9):1175\u20131180","journal-title":"Mult Scler"},{"issue":"3","key":"9201_CR63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1827.2006.01936.x","volume":"56","author":"K Takeuchi","year":"2006","unstructured":"Takeuchi K et al (2006) Prevalence of Epstein\u2013Barr virus in Japan: trends and future prediction. Pathol Int 56(3):112\u2013116","journal-title":"Pathol Int"},{"issue":"3","key":"9201_CR64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","volume":"59","author":"EL Thacker","year":"2006","unstructured":"Thacker EL et al (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59(3):499\u2013503","journal-title":"Ann Neurol"},{"issue":"1","key":"9201_CR65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson DA (2001) Epstein\u2013Barr virus: exploiting the immune system. Nat Rev Immunol 1(1):75\u201382","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9201_CR66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","volume":"162","author":"AC Sechel van","year":"1999","unstructured":"van Sechel AC et al (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 162(1):129\u2013135","journal-title":"J Immunol"},{"key":"9201_CR67","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00069-0","volume":"69","author":"JH Vaughn","year":"1996","unstructured":"Vaughn JH et al (1996) An Epstein\u2013Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway. J Neuroimmunol 69:95\u2013102","journal-title":"J Neuroimmunol"},{"key":"9201_CR68","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1468-1331.2004.00871.x","volume":"11","author":"H-J Wagner","year":"2004","unstructured":"Wagner H-J et al (2004) Plasma viral load of Epstein\u2013Barr virus and risk of multiple sclerosis. Eur J Neurol 11:833\u2013834","journal-title":"Eur J Neurol"},{"issue":"2","key":"9201_CR69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","volume":"55","author":"K Wandinger","year":"2000","unstructured":"Wandinger K et al (2000) Association between clinical disease activity and Epstein\u2013Barr virus reactivation in MS. Neurology 55(2):178\u2013184","journal-title":"Neurology"},{"key":"9201_CR70","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(81)91527-0","volume":"2","author":"HB Warner","year":"1981","unstructured":"Warner HB, Carp RI (1981) Multiple sclerosis and Epstein\u2013Barr virus (letter). Lancet 2:1290","journal-title":"Lancet"},{"issue":"Pt 12","key":"9201_CR71","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN et al (2009) Epstein\u2013Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132(Pt 12):3318\u20133328","journal-title":"Brain"},{"issue":"3","key":"9201_CR72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1352458507084265","volume":"14","author":"BM Zaadstra","year":"2008","unstructured":"Zaadstra BM et al (2008) Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler 14(3):307\u2013313","journal-title":"Mult Scler"},{"issue":"6","key":"9201_CR73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.2008.154906","volume":"80","author":"R Zivadinov","year":"2009","unstructured":"Zivadinov R et al (2009) Epstein\u2013Barr Virus is associated with gray matter atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 80(6):620\u2013625","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-010-9201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-010-9201-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-010-9201-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:14:32Z","timestamp":1685556872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-010-9201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,6]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9201"],"URL":"https:\/\/doi.org\/10.1007\/s11481-010-9201-3","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,6]]}}}